AboutContactsEditorial StaffEditorial CouncilArchiveFor AuthorsFor Reviewers

The Role of the Genes of Immune Response in the Development of Type 2 Diabetes

Journal «MEDICINA» ¹ 4, 2022, pp.1-9 (Research)

Authors

Kochetova O. V.
PhD (Biology), Senior Researcher1

Avzaletdinova D. S.
MD, PhD, Assistant Professor, Chair for Endocrinology2

Korytina G. F.
Doctor of Biology, Professor, Chief Researcher1

Morugova T. V.
Doctor of Medicine, Professor, Head, Chair for Endocrinology2

Boboedova O. V.
Resident Doctor, Chair for Endocrinology2

1 - Institute of Biochemistry and Genetics – Subdivision of the Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russian Federation
2 - Federal State Budgetary Educational Institution of Higher Education «Bashkir State Medical University» of Healthcare Ministry of the Russian Federation, Ufa, Russian Federation

Corresponding Author

Avzaletdinova Diana; e-mail: hyppocrat@mail.ru.

Conflict of interest

None declared.

Funding

The study was supported by the Russian Science Foundation (No. 22-25-00010).

Abstract

Type 2 diabetes mellitus (T2D) is a complex chronic disease resulting from a lot of factors, including insulin resistance. One of the causes of the insulin resistance is the presence of chronic inflammation. This study aimed to analyze polymorphisms of genes of pro-inflammatory cytokines and their receptors (the gene coding tumor necrosis factor receptor superfamily member 1B TNFRSF1B, the genes coding A and B subunits of interleukin 12 IL12A, IL12B) and C-reactive protein (CRP) with T2D in Tatars. The single nucleotide polymorphism (SNP) rs568408 in IL12A (PFDR=0.00005, OR=5.28) was significantly associated with type 2 diabetes. Regression analysis revealed that rs3212227 in IL12Â was associated with the glycated hemoglobin HbA1c level and fasting blood glucose (Ð=0.0017 and Ð=0.03, respectively).

Key words

type 2 diabetes mellitus, inflammation, C-reactive protein, pro-inflammatory cytokines

DOI

References

1. Dedov I.I., Shestakova M.V., Majorov A.Yu., et al. Saharnyj diabet 2 tipa u vzroslyh. [Type 2 diabetes mellitus in adults.] Saharnyj diabet [Diabetes mellitus] 2020; 23(2S): 4-102, doi: 10.14341/DM12507 (In Russ.)

2. Nicholas D.A., Proctor E.A., Agrawal M. et al. Fatty Acid Metabolites Combine with Reduced β Oxidation to Activate Th17 Inflammation in Human Type 2 Diabetes. Cell Metab. 2019; 30(3): 447-461.e5, doi: 10.1016/j.cmet.2019.07.004

3. Teng M.W., Bowman E.P., McElwee J.J., Smyth M.J., Casanova J.L., Cooper A.M., Cua D.J. IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases. Nat Med. 2015; 21(7): 719-29, doi: 10.1038/nm.3895

4. Pedula Ê.L., Nichols G.A., Hillier Ò.A. Diabetes is associated with inflammation independent of obesity: a community-based sample of routine care patients. Diabetologia 2007; 50: S118. Abstr. 0267.

5. Kahn S.E., Zinman B., Haffner S.M., et al. ADOPT Study Group. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes 2006; 5(8): 2357-2364, doi: 10.2337/db06-0116

6. Martínez-García M.Á., Moncayo S., Insenser M., et al. Metabolic Cytokines at Fasting and During Macronutrient Challenges: Influence of Obesity, Female Androgen Excess and Sex. Nutrients 2019; 11(11): 2566, doi: 10.3390/nu11112566

7. Roszak A., Mostowska A., Sowińska A. et al. Contribution of IL12A and IL12B polymorphisms to the risk of cervical cancer. Pathol Oncol Res. 2012; 18(4): 997-1002, doi: 10.1007/s12253-012-9532-x

8. Gauderman W.J. Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol. 2002; 155(5): 478-84, doi: 10.1093/aje/155.5.478

9. Kochetova O.V., Avzaletdinova D.S., Korytina G.F., Morugova T.V., Mustafina O.E. The association between eating behavior and polymorphisms in GRIN2B, GRIK3, GRIA1 and GRIN1 genes in people with type 2 diabetes mellitus. Mol Biol Rep. 2020; 47(3): 2035-2046, doi: 10.1007/s11033-020-05304-x

10. Purcell S., Neale B., Todd-Brown K. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007; 81(3): 559-75, doi: 10.1086/519795

11. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the royal statistical society. Series B (Methodological) 1995; 57(1): 289-300.

12. de Moura E.L., Dos Santos A.C., et al. Association of Polymorphisms in Cytokine genes with susceptibility to Precancerous Lesions and Cervical Cancer: A systematic review with meta-analysis. Immunol Invest. 2021; 50(5): 492-526, doi: 10.1080/08820139.2020.1778023

13. Vázquez-Vázquez C., Posadas-Sánchez R., Fragoso J.M., et al. IL-12B polymorphisms are associated with the presence of premature coronary artery disease and with cardiovascular risk factors: the genetics of atherosclerotic disease Mexican Study. DNA and Cell Biology 2020; 39(7): 1347-1355.

14. Wei P., Kou W., Zhang C. et al. Genetic variations in interleukin-12B in allergic rhinitis. Immunol Res. 2016; 64(1): 329-36, doi: 10.1007/s12026-015-8758-6